Pfizer (id:8482 PFE)
26.59 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/23/2024 1:48:57 PM)
Exchange open, closes in 2 hours 11 minutes
About Pfizer
Market Capitalization 149.58B
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
| Headquarters (address) |
66 Hudson Boulevard East New York 10001-2192 NY United States |
| Phone | 212 733 2323 |
| Website | https://www.pfizer.com |
| Employees | 88K |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Ticker | PFE |
| Exchange | New York Stock Exchange |
| Currency | USD |
| 52 week range | 24.48 - 31.54 |
| Market Capitalization | 149.58B |
| Dividend yield forward | 6.37 % |
| Dividend yield forward United States (ID:6, base:1858) | 4.48 % |
| P/E trailing | 35.19 |
| P/E forward | 9.01 |
| Price/Sale | 2.52 |
| Price/Book | 1.62 |
| Beta | 3.00 |
| EPS | 3.00 |
| EPS United States (ID:6, base:3382) | 24.33 |
Dividend growth streak
Pfizer has raised their dividend 13.00 years in a row. This is above the 4.499729 year average in the 'Drug Manufacturers General' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Pfizer has raised their dividend 6.37 years in a row. This is below the 42121.954600 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Pfizer has raised their dividend 3.82 years in a row. This is below the 12.560500 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Pfizer has raised their dividend 5.50 years in a row. This is below the 10.207200 year average in the 'Drug Manufacturers General' industry
Payout Ratio
Payout Ratio: Pfizer has raised their dividend 222.67 years in a row. This is above the 148.467900 year average in the 'Drug Manufacturers General' industry
Self funded year
Pfizer years needed to self fund. This is below the 34.112811 year average in the 'Drug Manufacturers General' industry
Dividend growth streak
Pfizer has raised their dividend 13.00 years in a row. This is above the 4.499729 year average in the 'Drug Manufacturers General' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Pfizer has raised their dividend 6.37 years in a row. This is below the 42121.954600 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Pfizer has raised their dividend 3.82 years in a row. This is below the 12.560500 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Pfizer has raised their dividend 5.50 years in a row. This is below the 10.207200 year average in the 'Drug Manufacturers General' industry
Payout Ratio
Payout Ratio: Pfizer has raised their dividend 222.67 years in a row. This is above the 148.467900 year average in the 'Drug Manufacturers General' industry
Self funded year
Pfizer years needed to self fund. This is below the 34.112811 year average in the 'Drug Manufacturers General' industry